EBS · Emergent Biosolutions Inc
United States · RS rating 31 · As of 2026-10-14
| Price | 6.91 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 31 / 93 / 32 / 23 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 16 / 12 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -214.3% |
| Sales growth Q/Q | -35.2% |
| Distance from 52-week high | +50.3% |
| Market cap (USD) | $417.8M |